Effect of cardiopulmonary bypass on cytochrome P450 enzyme activity: implications for pharmacotherapy

References

• Abdel-Razzak ZLP, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, Guillouzo A 1993. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 44:707–715.
   PubMed Web of Science ®Google Scholar
• Aitken AE, Morgan ET. 2007. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos. 35:1687–1693.
   PubMed Web of Science ®Google Scholar
• Asokumar B, Cheng D, Chung F, Peniston C, Sandler A, Varin F. 1998. Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery. Can J Anaesth. 45:515–520.
   PubMed Web of Science ®Google Scholar
• Bartels K, Ma Q, Venkatraman TN, Campos CR, Smith L, Cannon RE, Podgoreanu MV, Lascola CD, Miller DS, Mathew JP. 2014. Effects of deep hypothermic circulatory arrest on the blood brain barrier in a cardiopulmonary bypass model: a pilot study. Heart Lung Circul. 23:981–984.
   PubMed Web of Science ®Google Scholar
• Beer J, Wagner CC, Zeitlinger M. 2009. Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing. Aaps J. 11:1–12.
   PubMed Web of Science ®Google Scholar
• Booker PD, Taylor C, Saba G. 1996. Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery. Br J Anaesth. 76:365–368.
   PubMed Web of Science ®Google Scholar
• Bovill JG, Sebel PS. 1980. Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery. Br J Anaesth. 52:795–801.
   PubMed Web of Science ®Google Scholar
• Buylaert WA, Herregods LL, Mortier EP, Bogaert MG. 1989. Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. Clin Pharmacokinet. 17:10–26.
   PubMed Web of Science ®Google Scholar
• Calleja C, Eeckhoutte C, Larrieu G, Dupuy J, Pineau T, Galtier P. 1997. Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes. Biochem Biophys Res Commun. 239: 273–278.
   PubMed Web of Science ®Google Scholar
• Carmona MJ, Pereira VA, Malbouisson LM, Auler JO, Jr, Santos SR. 2009. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol. Braz J Med Biol Res. 42:574–581.
   PubMed Web of Science ®Google Scholar
• Chen YL, Le Vraux V, Leneveu A, Dreyfus F, Stheneur A, Florentin I, De Sousa M, Giroud JP, Flouvat B, Chauvelot-Moachon L. 1994. Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther. 55:649–660.
   PubMed Web of Science ®Google Scholar
• Cook DR, Freeman JA, Lai AA, Robertson KA, Kang Y, Stiller RL, Aggarwal S, Abou-Donia MM, Welch RM. 1991. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Anesth Analg. 72:145–150.
   PubMed Web of Science ®Google Scholar
• Cotogni P, Passera R, Barbero C, Gariboldi A, Moscato D, Izzo G, Rinaldi M. 2013. Intraoperative vancomycin pharmacokinetics in cardiac surgery with or without cardiopulmonary bypass. Ann Pharmacother. 47:455–463.
   PubMed Web of Science ®Google Scholar
• Coutant DE, Kulanthaivel P, Turner PK, Bell RL, Baldwin J, Wijayawardana SR, Pitou C, Hall SD. 2015. Understanding disease–drug interactions in cancer patients: implications for dosing within the therapeutic window. Clin Pharmacol Ther. 98:76–86.
   PubMed Web of Science ®Google Scholar
• Dieleman JM, van Paassen J, van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, van der Heijden GJ, Dekkers OM. 2011. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev. 2011;CD005566.
   PubMed Web of Science ®Google Scholar
• Diodato M, Chedrawy EG. 2014. Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation. Surg Res Pract. 2014:726158
   PubMedGoogle Scholar
• Dreisbach AW, Flessner MF. 2015. Drug metabolism and chronic kidney disease. In: Chronic renal disease. Waltham (MA): Elsevier Inc; p. 674–681 (Chapter 55).
   Google Scholar
• Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. 2003. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother. 47:1318–1323.
   PubMed Web of Science ®Google Scholar
• El Azab SR, Doha N, Rady A, El-Sayed AE, Abd-Rabo M. 2010. The cytokine balance during CABG surgery with and without cardiopulmonary bypass. Egyptian Journal of Anaesthesia. 26:281–286.
   Google Scholar
• Elkahwaji J, Robin MA, Berson A, Tinel M, Letteron P, Labbe G, Beaune P, Elias D, Rougier P, Escudier B, et al. 1999. Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol. 57:951–954.
   PubMed Web of Science ®Google Scholar
• Flezzani P, Alvis MJ, Jacobs JR, Schilling MM, Bai S, Reves JG. 1987. Sufentanil disposition during cardiopulmonary bypass. Can J Anaesth. 34:566–569.
   PubMed Web of Science ®Google Scholar
• Frye RF, Schneider VM, Frye CS, Feldman AM. 2002. Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. J Card Fail. 8:315–319.
   PubMed Web of Science ®Google Scholar
• Frye RF, Zgheib NK, Matzke GR, Chaves-Gnecco D, Rabinovitz M, Shaikh OS, Branch RA. 2006. Liver disease selectively modulates cytochrome P450-mediated metabolism. Clin Pharmacol Ther. 80:235–245.
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Ishida N, Noguchi T, Kappas A, Sassa S. 1992. Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells. Biochem Biophys Res Commun. 184:960–965.
   PubMed Web of Science ®Google Scholar
• Gasz B, Lenard L, Racz B, Benko L, Borsiczky B, Cserepes B, Gal J, Jancso G, Lantos J, Ghosh S, et al. 2006. Effect of cardiopulmonary bypass on cytokine network and myocardial cytokine production. Clin Cardiol. 29:311–315.
   PubMed Web of Science ®Google Scholar
• Gedney JA, Ghosh S. 1995. Pharmacokinetics of analgesics, sedatives and anaesthetic agents during cardiopulmonary bypass. Br J Anaesth. 75:344–351.
   PubMed Web of Science ®Google Scholar
• Giomarelli P, Scolletta S, Borrelli E, Biagioli B. 2003. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg. 76:117–123.
   PubMed Web of Science ®Google Scholar
• Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B. 2000. In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther. 67:32–43.
   PubMed Web of Science ®Google Scholar
• Goucke CR, Hackett LP, Barrett PH, Ilett KF. 2007. Blood concentrations of enflurane before, during, and after hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 21:218–223.
   PubMed Web of Science ®Google Scholar
• Grassin-Delyle S, Tremey B, Abe E, Fischler M, Alvarez JC, Devillier P, Urien S. 2013. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 111:916–924.
   PubMed Web of Science ®Google Scholar
• Greilich PE, Brouse CF, Whitten CW, Chi L, Dimaio JM, Jessen ME. 2003. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. J Thorac Cardiovasc Surg. 126:1498–1503.
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Haase-Fielitz A. 2010. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol. 55:2024–2033.
   PubMed Web of Science ®Google Scholar
• Hall R. 2000. Changes in pharmacokinetics and pharmacodynamics of drugs administered during cardiopulmonary bypass. In: Cardiopulmonary bypass: principles and practice, 2nd ed. Philadelphia (PA): Wolters Kluwer (Chapter 14).
   Google Scholar
• Halter J, Steinberg J, Fink G, Lutz C, Picone A, Maybury R, Fedors N, DiRocco J, Lee HM, Nieman G. 2005. Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol. 37:272–277.
   PubMedGoogle Scholar
• Hirai S. 2003. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 9:365–370.
   PubMedGoogle Scholar
• Holley FO, Ponganis KV, Stanski DR. 1982. Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharmacokinet. 7:234–251.
   PubMed Web of Science ®Google Scholar
• Hudson RJ, Thomson IR, Jassal R. 2004. Effects of cardiopulmonary bypass on sufentanil pharmacokinetics in patients undergoing coronary artery bypass surgery. Anesthesiology. 101:862–871.
   PubMed Web of Science ®Google Scholar
• Hug CC, Burm AG, de Lange S. 1994. Alfentanil pharmacokinetics in cardiac surgical patients. Anesth Analg. 78:231–239.
   PubMed Web of Science ®Google Scholar
• Hynynen M, Hynninen M, Soini H, Neuvonen PJ, Heinonen J. 1994. Plasma concentration and protein binding of alfentanil during high-dose infusion for cardiac surgery. Br J Anaesth. 72:571–576.
   PubMed Web of Science ®Google Scholar
• Jeleazcov C, Saari TI, Ihmsen H, Schuttler J, Fechner J. 2012. Changes in total and unbound concentrations of sufentanil during target controlled infusion for cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 109:698–706.
   PubMed Web of Science ®Google Scholar
• Kacevska M, Robertson GR, Clarke SJ, Liddle C. 2008. Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing. Expert Opin Drug Metab Toxicol. 4:137–149.
   PubMed Web of Science ®Google Scholar
• Khabar KS, elBarbary MA, Khouqeer F, Devol E, Al-Gain S, Al-Halees Z. 1997. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 85:97–103.
   PubMedGoogle Scholar
• Khabar KSA, AlZoghaibi F, Murayama T, Matsushima K, Mukaida N, Siddiqui Y, Dhalla M, AlAhdal MN. 1997. Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochemical and Biophysical Research Communications. 235:774–778.
   PubMed Web of Science ®Google Scholar
• Khuenl-Brady KS, Sparr H. 1996. Clinical pharmacokinetics of rocuronium bromide. Clin Pharmacokinet. 31:174–183.
   PubMed Web of Science ®Google Scholar
• Klamerus KJ, Rodvold KA, Silverman NA, Levitsky S. 1988. Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition. Antimicrob Agents Chemother. 32:631–635.
   PubMed Web of Science ®Google Scholar
• Kong AN, Jungbluth GL, Pasko MT, Beam TR, Jusko WJ. 1990. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass. Pharmacotherapy. 10:29–34.
   PubMed Web of Science ®Google Scholar
• Koska AJ, Romagnoli A, Kramer WG. 1981. Effect of cardiopulmonary bypass on fentanyl distribution and elimination. Clin Pharmacol Ther. 29:100–105.
   PubMed Web of Science ®Google Scholar
• Krivoy N, Yanovsky B, Kophit A, Zaher A, Bar-El Y, Adler Z, Gaitini L, Milo S. 2002. Vancomycin sequestration during cardiopulmonary bypass surgery. J Infect. 45:90–95.
   PubMed Web of Science ®Google Scholar
• Kumar K, Crankshaw DP, Morgan DJ, Beemer GH. 1988. The effect of cardiopulmonary bypass on plasma protein binding of alfentanil. Eur J Clin Pharmacol. 35:47–52.
   PubMed Web of Science ®Google Scholar
• Lee BL, Sachdeva M, Chambers HF. 1991. Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrob Agents Chemother. 35:2505–2508.
   PubMed Web of Science ®Google Scholar
• Lehot JJ, Boulieu R, Foussadier A, George M, Clerc J, Villard J, Chassignolle J, Ferry S, Estanove S. 1993. Comparison of the pharmacokinetics of methohexital during cardiac surgery with cardiopulmonary bypass and vascular surgery. J Cardiothorac Vasc Anesth. 7:30–34.
   PubMedGoogle Scholar
• Liebold A, Keyl C, Birnbaum DE. 1999. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg. 15:340–345.
   PubMed Web of Science ®Google Scholar
• Marieke A, Peter GJH, Wobbe H, Michel LH, Alexander JS. 2015. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass. Int J Clin Pharm. 37:592–598.
   PubMed Web of Science ®Google Scholar
• Massoudy P, Zahler S, Becker BF, Braun SL, Barankay A, Meisner H. 2001. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 119:31–36.
   PubMed Web of Science ®Google Scholar
• Mathie RT. 1993. Hepatic blood flow during cardiopulmonary bypass. Crit Care Med. 21: S72–S76.
   PubMed Web of Science ®Google Scholar
• Matthew JH, Tyree HK, Clark L, Douglas NF, Gerard RB, Michael FW, Joseph CC. 2014. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery. J Thoracic Cardiovasc Surg. 147: 1925–1930.
   PubMed Web of Science ®Google Scholar
• McCormack PL. 2012. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 72:585–617.
   PubMed Web of Science ®Google Scholar
• McDonald CI, Fraser JF, Coombes JS, Fung YL. 2014. Oxidative stress during extracorporeal circulation. Eur J Cardiothorac Surg. 46:937–943.
   PubMed Web of Science ®Google Scholar
• Merrell MD, Cherrington NJ. 2011. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab Rev. 43:317–334.
   PubMed Web of Science ®Google Scholar
• Mets B. 2000. The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass. Acta Anaesthesiol Scand. 44:261–273.
   PubMed Web of Science ®Google Scholar
• Michelsen LG, Holford NH, Lu W, Hoke JF, Hug CC, Bailey JM. 2001. The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Anesth Analg. 93:1100–1105.
   PubMed Web of Science ®Google Scholar
• Miglioli PA, Merlo F, Fabbri A, Padrini R. 1997. Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardio-pulmonary bypass surgery. J Antimicrob Chemother. 39:229–233.
   PubMed Web of Science ®Google Scholar
• Miglioli PA, Merlo F, Grabocka E, Padrini R. 1998. Effects of cardio-pulmonary bypass on vancomycin plasma concentration decay. Pharmacol Res. 38:275–278.
   PubMed Web of Science ®Google Scholar
• Miller RS, Peterson GM, McLean S, Moller C. 1997. Effect of cardiopulmonary bypass on the plasma concentrations of fentanyl and alcuronium. J Clin Pharm Ther. 22:197–205.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Grocott HP, Phillips-Bute B, Mathew JP, Newman MF, Bar-Yosef S. 2007. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine. 38:37–42.
   PubMed Web of Science ®Google Scholar
• Morgan ET. 2009. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther. 85:434–438.
   PubMed Web of Science ®Google Scholar
• Muntane-Relat J, Ourlin JC, Domergue J, Maurel P. 1995. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology. 22:1143–1153.
   PubMed Web of Science ®Google Scholar
• Neusa MHB, Elisângela C, Marta FD, Eduardo FMC, Rochelle SS, Anelise L, Ige JK, João BTR. 2014. Inflammatory response in patients under coronary artery bypass grafting surgery and clinical implications: a review of the relevance of dexmedetomidine use. ISRN Anesthesiol. 2014:28.
   Google Scholar
• Nguyen MH, Eells SJ, Tan J, Sheth CT, Omari B, Flores M, Wang J, Miller LG. 2011. Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery. Antimicrob Agents Chemother. 55:2499–2505.
   PubMed Web of Science ®Google Scholar
• Nitzschke R, Wilgusch J, Kersten JF, Trepte CJ, Haas SA, Reuter DA, Goetz AE, Goepfert MS. 2013. Changes in sevoflurane plasma concentration with delivery through the oxygenator during on-pump cardiac surgery. Br J Anaesth. 110:957–965.
   PubMed Web of Science ®Google Scholar
• Okutani R, Philbin DM, Rosow CE, Koski G, Schneider RC. 1988. Effect of hypothermic hemodilutional cardiopulmonary bypass on plasma sufentanil and catecholamine concentrations in humans. Anesth Analg. 67:667–670.
   PubMed Web of Science ®Google Scholar
• Ortega GM, Marti-Bonmati E, Guevara SJ, Gomez IG. 2003. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery. Am J Health Syst Pharm. 60:260–265.
   PubMed Web of Science ®Google Scholar
• Paruk F, Fekade BS, Lipman J, Roberts JA. 2017. Dosing antibiotic prophylaxis during cardiopulmonary bypass: a higher level of complexity? A structured review. Int J Antimicrob Agents. 49:395–402.
   PubMed Web of Science ®Google Scholar
• Plachetka JR, Salomon NW, Copeland JG. 1981. Plasma propranolol before, during, and after cardiopulmonary bypass. Clin Pharmacol Ther. 30:745–751.
   PubMed Web of Science ®Google Scholar
• Prondzinsky R, Knupfer A, Loppnow H, Redling F, Lehmann DW, Stabenow I, Witthaut R, Unverzagt S, Radke J, Zerkowski HR, et al. 2005. Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg. 129:760–766.
   PubMed Web of Science ®Google Scholar
• Punjabi PP, Taylor KM. 2013. The science and practice of cardiopulmonary bypass: from cross circulation to ECMO and SIRS. Glob Cardiol Sci Pract. 2013:249–260.
   PubMedGoogle Scholar
• Robbins GR, Wynands JE, Whalley DG, Donati F, Ramsay JG, Srikant CB, Patel YC. 1990. Pharmacokinetics of alfentanil and clinical responses during cardiac surgery. Can J Anaesth. 37:52–57.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Stove V, De Waele JJ, Sipinkoski B, McWhinney B, Ungerer JP, Akova M, Bassetti M, Dimopoulos G, Kaukonen KM, et al. 2014. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study. Int J Antimicrob Agents. 43:423–430.
   PubMed Web of Science ®Google Scholar
• Roth-Isigkeit A, Hasselbach L, Ocklitz E, Bruckner S, Ros A, Gehring H, Schmucker P, Rink L, Seyfarth M. 2001. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clin Exp Immunol. 125:80–88.
   PubMed Web of Science ®Google Scholar
• Russell D, Royston D, Rees PH, Gupta SK, Kenny GN. 1997. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil. Br J Anaesth. 79:456–459.
   PubMed Web of Science ®Google Scholar
• Saari TI, Ihmsen H, Mell J, Frohlich K, Fechner J, Schüttler J, Jeleazcov C. 2014. Influence of intensive care treatment on the protein binding of sufentanil and hydromorphone during pain therapy in postoperative cardiac surgery patients. Br J Anaesth. 113: 677–687.
   PubMed Web of Science ®Google Scholar
• Sablotzki A, Friedrich I, Muhling J, Dehne MG, Spillner J, Silber RE, Czeslik E. 2002. The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion. 17:103–109.
   PubMed Web of Science ®Google Scholar
• Sato H, Naito T, Ishida T, Kawakami J. 2016. Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachetic cancer patients. Eur J Clin Pharmacol. 72:1463–1470.
   PubMed Web of Science ®Google Scholar
• Singh D, Kashyap A, Pandey RV, Saini KS. 2011. Novel advances in cytochrome P450 research. Drug Discov Today. 16:793–799.
   PubMed Web of Science ®Google Scholar
• Smeulers NJ, Wierda JM, van den Broek L, Gallandat Huet RC, Hennis PJ. 1995. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium. J Cardiothorac Vasc Anesth. 9:700–705.
   PubMed Web of Science ®Google Scholar
• Trop S, Marshall JC, Mazer CD, Gupta M, Dumont DJ, Bourdeau A, Verma S. 2014. Perioperative cardiovascular system failure in South Asians undergoing cardiopulmonary bypass is associated with prolonged inflammation and increased Toll-like receptor signaling in inflammatory monocytes. J Surg Res. 187:43–52.
   PubMed Web of Science ®Google Scholar
• Wiesner G, Taeger K, Peter K. 1996. Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis. Anaesthesist. 45:323–329.
   PubMed Web of Science ®Google Scholar
• Withington D, Menard G, Varin F. 2011. Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children. Paediatr Anaesth. 21:341–346.
   PubMed Web of Science ®Google Scholar
• Wood T, Thoresen M. 2015. Physiological responses to hypothermia. Seminars in Fetal & Neonatal Medicine. 20:87–96.
   PubMed Web of Science ®Google Scholar
• Yano R, Nakamura T, Tsukamoto H, Igarashi T, Goto N, Wakiya Y, Masada M. 2007. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations. Ther Drug Monit. 29:399–403.
   PubMed Web of Science ®Google Scholar
• Yeung CK, Shen DD, Thummel KE, Himmelfarb J. 2014. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport. Kidney Int. 85:522–528.
   PubMed Web of Science ®Google Scholar
• Zakkar M, Guida G, Suleiman MS, Angelini GD. 2015. Cardiopulmonary bypass and oxidative stress. Oxid Med Cell Longev. 2015:189863
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang D, Fakhoury M, Fahd M, Duquesne F, Storme T, Baruchel A, Jacqz-Aigrain E. 2014. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease. Antimicrob Agents Chemother. 58:3191–3199.
   PubMed Web of Science ®Google Scholar